Assignee
I MAB BIOPHARMA CO LTD
CN·2 granted patents·5 pending applications·1 citations·filing 2017–2023
Top patents by PatentIndex Score
7 records- 0172US10647767B2Anti-GM-CSF antibodies and uses thereofI MAB BIOPHARMA CO LTD·Filed 2017·Granted May 12, 2020·1 cites·22 claims
- 0259US2025074995A1Multispecific constructs and uses thereofI MAB BIOPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0358US2025352645A1Biomarkers and methods for treating nsclcI MAB BIOPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0457US10889641B2Anti-GM-CSF antibodies and uses thereofI MAB BIOPHARMA CO LTD·Filed 2018·Granted Jan 12, 2021·0 cites·14 claims
- 0554US2023399400A1Novel anti-cd47 antibodies and uses thereofI MAB BIOPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 0652US2024209093A1Single domain pd-l1 antibodiesI MAB BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 0746US2024101698A1Formulations of anti-cd73 antibodiesI MAB BIOPHARMA CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when I MAB BIOPHARMA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →